Renin-Angiotensin system blockade for diabetic nephropathy prevention

Am J Cardiol. 2010 May 15;105(10):1505. doi: 10.1016/j.amjcard.2010.02.004.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage*
  • Benzimidazoles / administration & dosage
  • Biphenyl Compounds
  • Diabetes Mellitus, Type 1 / diagnosis
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetic Nephropathies / prevention & control*
  • Enalapril / administration & dosage
  • Female
  • Humans
  • Losartan / administration & dosage
  • Male
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Renin-Angiotensin System / drug effects*
  • Risk Assessment
  • Tetrazoles / administration & dosage
  • Treatment Outcome

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Benzimidazoles
  • Biphenyl Compounds
  • Tetrazoles
  • Enalapril
  • Losartan
  • candesartan